Evidence map›Paper›PMID 28847966›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

The molecular dynamics of long noncoding RNA control of transcription in PTEN and its pseudogene.

Nicholas Lister, Galina Shevchenko, James L Walshe, Jessica Groen, Per Johnsson, Linda Vidarsdóttir, Dan Grander, Sandro F Ataide, Kevin V Morris

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. The Roles of PTEN in Melanoma Suppression.Pigment cell & melanoma research · 2025
    Review
  3. Review
  4. How MicroRNAs Command the Battle against Cancer.International journal of molecular sciences · 2024
    Review
  5. Article
  6. Cancers · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Pseudogenes: A Novel Source of Trans-Acting Antisense RNAs.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  12. Pseudogenes: Four Decades of Discovery.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 3 countries.

Nicholas ListerThe University of New South Wales, Biotechnology and Biomedical Sciences, Sydney, NSW 2052, Australia.
Galina ShevchenkoCenter for Gene Therapy, City of Hope-Beckman Research Institute at the City of Hope, Duarte, CA 91010.
James L WalsheSchool of Life and Environmental Sciences, The University of Sydney, Sydney, NSW 2006, Australia.
Jessica GroenThe University of New South Wales, Biotechnology and Biomedical Sciences, Sydney, NSW 2052, Australia.
Per JohnssonDepartment of Cell and Molecular Biology, Ludwig Institute for Cancer Research, Karolinska Institutet, 171 65 Stockholm, Sweden.
Linda VidarsdóttirDepartment of Oncology-Pathology, Cancer Center Karolinska, R8:03, Karolinska Hospital and Institute, S-171 76 Stockholm, Sweden.
Dan GranderDepartment of Oncology-Pathology, Cancer Center Karolinska, R8:03, Karolinska Hospital and Institute, S-171 76 Stockholm, Sweden.
Sandro F AtaideSchool of Life and Environmental Sciences, The University of Sydney, Sydney, NSW 2006, Australia.
Kevin V MorrisCenter for Gene Therapy, City of Hope-Beckman Research Institute at the City of Hope, Duarte, CA 91010; kmorris@coh.org.
Karolinska University Hospital · SEUniversity of Sydney · AUUNSW Sydney · AUBeckman Research InstituteCity of Hope · USLudwig Cancer Research · SE

Funding

Targeted Delivery Vechicles for OligonucleotidesP01AI099783 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI AKKINA, RAMESH · 2012 to 2016
$7.4M
Transcriptional control, targeted modification, and excision of HIV in the brainR01MH113407 · NIMH · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI BURNETT, JOHN CORY · 2017 to 2021
$3.0M
Targeted inhibition of HIV-1 latencyR01AI111139 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI MORRIS, KEVIN V · 2014 to 2018
$2.7M
Activating cystic fibrosis transmembrane conductance regulator: the therapeutic potential of RNA directed gene activationR01DK104681 · NIDDK · SCRIPPS RESEARCH INSTITUTE, THE · PI MORRIS, KEVIN V · 2015 to 2019
$1.9M
NIAID NIH HHS P01 AI099783NIAID NIH HHS R01 AI111139NIDDK NIH HHS R01 DK104681NIMH NIH HHS R01 MH113407
6 · The paper itself

Abstract

RNA has been found to interact with chromatin and modulate gene transcription. In human cells, little is known about how long noncoding RNAs (lncRNAs) interact with target loci in the context of chromatin. We find here, using the phosphatase and tensin homolog (PTEN) pseudogene as a model system, that antisense lncRNAs interact first with a 5' UTR-containing promoter-spanning transcript, which is then followed by the recruitment of DNA methyltransferase 3a (DNMT3a), ultimately resulting in the transcriptional and epigenetic control of gene expression. Moreover, we find that the lncRNA and promoter-spanning transcript interaction are based on a combination of structural and sequence components of the antisense lncRNA. These observations suggest, on the basis of this one example, that evolutionary pressures may be placed on RNA structure more so than sequence conservation. Collectively, the observations presented here suggest a much more complex and vibrant RNA regulatory world may be operative in the regulation of gene expression.

Indexed as

ChromatinChromatin Assembly and DisassemblyDNA Methyltransferase 3AExonsHEK293 CellsHumansMolecular Dynamics SimulationNucleic Acid ConformationPromoter Regions, GeneticPseudogenesPTEN PhosphohydrolaseRegulatory Elements, TranscriptionalRNA, Long NoncodingSequence Analysis, RNASequence HomologyChromatinDNA Methyltransferase 3ADNMT3A protein, humanPTEN PhosphohydrolasePTEN protein, humanRNA, Long NoncodingDNMT3aepigeneticpseudogenePTENPTENpg1

Identifiers

PMID28847966
PMCPMC5603994
OpenAlexW2745738280

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.